Bariatric Surgery and the Gut Hormone Response
Authors:
- Susan ThomasSTSusan Thomas
- Philip SchauerPSPhilip Schauer
- 22 April 2010
- journal article
- research article
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 25 (2) , 175-182
Abstract
Obesity has become an epidemic in the United States and is reaching epidemic levels in many other countries. Although obesity itself can have deleterious effects, the attributed comorbidities contribute greatly to the overall health decline of affected populations. Overweight and obese individuals are at increased risk for many diseases and health conditions. Medical, psychological, and endoscopic therapies for weight loss have been tried; however weight loss is usually only modest, with weight regain common. Bariatric surgery has been reported to be the most effective method for achieving major, long‐term weight loss, with weight loss ranges of 35%‐40% lasting as long as 15 years. Patients often lose weight at a rapid rate, with resolution or remission of many obesity‐related comorbidities. Although the procedure itself plays a role in the weight loss after surgery, the resultant metabolic changes have been linked to alterations in the gut hormones. Although these changes have been the focus of much research, they are not completely understood. Two hypotheses have been proposed to explain this conflicting data. The hindgut hypothesis suggests that the quick transit of nutrients to the distal bowel improves glucose metabolism by stimulating secretion of glucagon‐like peptide‐1 and other appetite‐suppressing gut peptides. The foregut hypothesis suggests that there is a yet unknown factor that promotes insulin resistance and type 2 diabetes mellitus. Further research is essential and could lead to less invasive therapies with fewer complications and side effects than bariatric surgery.Keywords
This publication has 44 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2009Diabetes Care, 2009
- Gastrointestinal surgery as treatment for type 2 diabetesCurrent Opinion in Endocrinology, Diabetes and Obesity, 2008
- Weight Loss, Appetite Suppression, and Changes in Fasting and Postprandial Ghrelin and Peptide-YY Levels After Roux-en-Y Gastric Bypass and Sleeve GastrectomyAnnals of Surgery, 2008
- Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgerySurgery for Obesity and Related Diseases, 2007
- The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 DiabetesAnnals of Surgery, 2006
- Surgery as an Effective Early Intervention for DiabesityDiabetes Care, 2005
- Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes MellitusAnnals of Surgery, 2003
- Ten and more years after vertical banded gastroplasty as primary operation for morbid obesityJournal of Gastrointestinal Surgery, 2000
- Gastric Partitioning for Morbid ObesityAnnals of Surgery, 1979
- AN EXPERIMENTAL EVALUATION OF THE NUTRITIONAL IMPORTANCE OF PROXIMAL AND DISTAL SMALL INTESTINEAnnals of Surgery, 1954